Scholarly Index
Afisi Ismaila
GlaxoSmithKline (United States); 7,328 total citations; 208 total publications; best world rank #290
GlaxoSmithKline (United States)
7,328Total citations
208Total publications
28H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Chronic Obstructive Pulmonary Disease (COPD) Research | 2021-2025 | 350 | US 83 | 95.60 |
| Asthma and respiratory diseases | 2021-2025 | 599 | US 146 | 94.47 |
| Inhalation and Respiratory Drug Delivery | 2021-2025 | 290 | US 64 | 88.56 |